FDA Approved: OMLONTI — Supplemental Application (Ocuvex Therapeutics, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for OMLONTI (omidenepag isopropyl) from Ocuvex Therapeutics, expanding the approved use of the ophthalmic solution f…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• OMLONTI (omidenepag isopropyl)

Snippet

SUPPL AP for OMLONTI (OMIDENEPAG ISOPROPYL)